🔗 Share this article

Treasury head Reeves has revealed she is preparing "specific action to address cost of living pressures" in the upcoming financial statement.

In comments to the BBC, she stated that lowering inflation is a shared responsibility of both the administration and the Bank of England.

The United Kingdom's price growth is forecast to be the highest among the G7 industrialized countries this year and next.

Possible Utility Cost Measures

Sources suggest the administration could take action to lower utility costs, for example by cutting the present 5% rate of value-added tax applied on energy.

Another possibility is to lower some of the regulatory levies currently added to household expenses.

Budgetary Constraints and Analyst Expectations

The administration will receive the next draft from the official forecaster, the OBR, on Monday, which will reveal how much space there is for such measures.

The consensus from the majority of experts is that Reeves will have to declare tax increases or expenditure reductions in order to fulfill her voluntary debt limits.

Earlier on Thursday, estimates suggested there was a £22 billion gap for the Treasury chief to address, which is at the lower end of projections.

"It is a collective task between the Bank of England and the government to further reduce some of the drivers of price increases," Reeves informed the BBC in Washington, at the yearly gatherings of the IMF and World Bank.

Tax Commitments and Global Concerns

While much of the focus has been on probable tax increases, the Treasury chief said the latest data from the fiscal watchdog had not changed her vow to campaign commitments not to increase tax levels on income tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with increasing geopolitical and commercial concerns for the fiscal tax moves, probably to be focused on those "with the broadest shoulders."

Global Trade Tensions

Commenting on worries about the UK's commercial links with the Asian nation she said: "The UK's security interests invariably are paramount."

Last week's declaration by China to strengthen export controls on rare earths and other resources that are crucial for advanced tech manufacturing led American leader the US President to threaten an additional 100% import tax on goods from China, increasing the risk of an all-out commercial conflict between the two global powers.

The American finance chief labeled China's action "economic coercion" and "a international production control attempt."

Inquired about accepting the American proposal to join its battle with the Asian nation, Reeves said she was "extremely troubled" by Chinese measures and called on the Chinese government "to avoid restrictions and restrict access."

She said the action was "damaging for the world economy and causes additional headwinds."

"I believe there are areas where we should confront China, but there are also valuable opportunities to export to Chinese markets, including financial services and other sectors of the economic system. We've got to maintain that equilibrium appropriate."

The Treasury chief also affirmed she was collaborating with other major economies "regarding our own essential resources strategy, so that we are less reliant."

NHS Drug Pricing and Investment

The Chancellor also admitted that the cost the National Health Service pays for pharmaceuticals could increase as a result of current negotiations with the Trump administration and its pharmaceutical firms, in return for lower tariffs and capital.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either halting or canceling operations in the United Kingdom, with some blaming the modest returns they are receiving.

Last month, the Science Minister said the cost the NHS pays for medicines would need to go up to prevent firms and drug research funding departing from the UK.

The Chancellor told the BBC: "It has been observed due to the cost structure, that drug testing, innovative medicines have not been offered in the United Kingdom in the way that they are in other EU nations."

"The objective is to guarantee that individuals getting treatment from the NHS are able to receive the finest life-saving medicines in the globe. And so we are looking at all of that, and... aiming to obtain more investment into the UK."